BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21209527)

  • 1. Correlation of serum free prostate-specific antigen level with histological findings in patients with prostatic disease.
    Lakhey M; Ghimire R; Shrestha R; Bhatta AD
    Kathmandu Univ Med J (KUMJ); 2010; 8(30):158-63. PubMed ID: 21209527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
    Obralic N; Kulovac B
    Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.
    Rovner ES; Schanne FJ; Malkowicz SB; Wein AJ
    J Urol; 1997 Jul; 158(1):138-41; discussion 141-2. PubMed ID: 9186340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
    Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
    Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
    Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA
    Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL.
    Chang CC; Lee YC; Tsai HW; Yii SC; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2015; 16(13):5261-4. PubMed ID: 26225663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer.
    Toubert ME; Guillet J; Chiron M; Meria P; Role C; Schlageter MH; Francois H; Borschneck C; Nivelon F; Desgrandchamps F; Rastel D; Cussenot O; Teillac P; Le Duc A; Najean Y
    Eur J Cancer; 1996 Nov; 32A(12):2088-93. PubMed ID: 9014750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of PSA and its fractions in the diagnosis of prostate cancer].
    Filella X; Truan D; Alcover J; Molina R; Luque P; Coca F; Ballesta AM
    Med Clin (Barc); 2004 Feb; 122(7):241-4. PubMed ID: 15012870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.
    Horninger W; Volgger H; Rogatsch H; Strohmeyer D; Steiner H; Hobisch A; Klocker H; Bartsch G
    J Urol; 2001 Apr; 165(4):1143-5. PubMed ID: 11257656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of free to total prostate-specific antigen in patients with prostatic intraepithelial neoplasia.
    Kiliç S; Kukul E; Danişman A; Güntekin E; Sevük M
    Eur Urol; 1998 Sep; 34(3):176-80. PubMed ID: 9732188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
    Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
    Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
    Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen.
    Morote J; Encabo G; Lopez M; de Torres IM
    BJU Int; 1999 Oct; 84(6):657-60. PubMed ID: 10510111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia.
    Mao Q; Zheng X; Jia X; Wang Y; Qin J; Yang K; Bai Y; Xie L
    Int Urol Nephrol; 2009 Dec; 41(4):761-6. PubMed ID: 19224388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M; Kraljić I
    Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.